O. M. Iziumska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
O. M. Iziumska has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Nataliia O. Pryimenko
POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE
6 shared publications - Tetiana Koval
POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE
4 shared publications - Galyna Dubynska
HSEE of Ukraine "Ukrainian Medical Stomatological Academy
3 shared publications - Olena H. Marchenko
Полтавський державний медичний університет
3 shared publications - Tetiana Kotelevska
Полтавський державний медичний університет
3 shared publications - Vadym A. Bodnar
Полтавський державний медичний університет
3 shared publications
Latest Publications
- Open Access
- 29 August 2025
- Published by Poltava State Medical University (PSMU) in The Medical and Ecological Problems
- Vol. 29 (2) , 18-25
ANALYSIS OF THE EPIDEMIOLOGICAL CHARACTERISTICS OF VIRAL HEPATITIS B AND C UNDER WARTIME CONDITIONS IN UKRAINE
Introduction. The epidemic of viral hepatitis B and C remains a significant problem for Ukraine. According to data from the Public Health Center of the Ministry of Health of Ukraine, approximately 5% of the population is infected with viral hepatitis C, and 1.5% with viral hepatitis B. During the war in Ukraine, the number of people tested for viral hepatitis B and C has increased, but the impact of individual risks and detailed changes in the epidemiological situation in the country and regions remains unexplored. Objective. To analyze changes in the epidemiological situation of viral hepatitis B and C in Ukraine and the Poltava region against the backdrop of military operations and to evaluate the effectiveness of testing. Methods. A retrospective analysis of the incidence of acute and chronic viral hepatitis B and C in Ukraine and the Poltava region for 2016-2024 was conducted. The study design was descriptive and analytical. Results. During 2023-2024, Ukraine saw a significant increase in the incidence of chronic hepatitis B to 4.0 per 100,000 population and chronic hepatitis C to 18.5 per 100,000 population in 2024, due to an increase in testing. The incidence of acute hepatitis B in Ukraine and the Poltava region was recorded at virtually the same levels and showed a similar trend – a sharp decline during the COVID-19 pandemic and a slight increase after the start of military operations. The increase in the ratio of chronic to acute hepatitis B to 2.32:1 in Ukraine and 8.37:1 in the Poltava region in 2024 indicates an increase in the effectiveness of testing. According to data from primary healthcare centers in the Poltava region, in 2023 there was an increase in the number of tests for HBsAg and antibodies to HCV and an increase in the proportion of positive results – 2.35% for HBsAg tests and 3.97% for HCV antibody tests, while according to data from the infectious diseases inpatient department, the figures were 4.86% and 17.03%, respectively. Conclusions. Against the backdrop of the war in Ukraine, there has been a significant increase in the incidence of chronic viral hepatitis B and C. There continues to be a significant prevalence of viral hepatitis C markers in the Ukrainian population compared to hepatitis B. The increase in the ratio of chronic hepatitis B to acute hepatitis B indicates an improvement in the effectiveness of population testing.
- 29 August 2025
- Published by Poltava State Medical University (PSMU) in The Medical and Ecological Problems
- Vol. 29 (2) , 18-25
Open AccessANALYSIS OF THE EPIDEMIOLOGICAL CHARACTERISTICS OF VIRAL HEPATITIS B AND C UNDER WARTIME CONDITIONS IN UKRAINE
Introduction. The epidemic of viral hepatitis B and C remains a significant problem for Ukraine. According to data from the Public Health Center of the Ministry of Health of Ukraine, approximately 5% of the population is infected with viral hepatitis C, and 1.5% with viral hepatitis B. During the war in Ukraine, the number of people tested for viral hepatitis B and C has increased, but the impact of individual risks and detailed changes in the epidemiological situation in the country and regions remains unexplored. Objective. To analyze changes in the epidemiological situation of viral hepatitis B and C in Ukraine and the Poltava region against the backdrop of military operations and to evaluate the effectiveness of testing. Methods. A retrospective analysis of the incidence of acute and chronic viral hepatitis B and C in Ukraine and the Poltava region for 2016-2024 was conducted. The study design was descriptive and analytical. Results. During 2023-2024, Ukraine saw a significant increase in the incidence of chronic hepatitis B to 4.0 per 100,000 population and chronic hepatitis C to 18.5 per 100,000 population in 2024, due to an increase in testing. The incidence of acute hepatitis B in Ukraine and the Poltava region was recorded at virtually the same levels and showed a similar trend – a sharp decline during the COVID-19 pandemic and a slight increase after the start of military operations. The increase in the ratio of chronic to acute hepatitis B to 2.32:1 in Ukraine and 8.37:1 in the Poltava region in 2024 indicates an increase in the effectiveness of testing. According to data from primary healthcare centers in the Poltava region, in 2023 there was an increase in the number of tests for HBsAg and antibodies to HCV and an increase in the proportion of positive results – 2.35% for HBsAg tests and 3.97% for HCV antibody tests, while according to data from the infectious diseases inpatient department, the figures were 4.86% and 17.03%, respectively. Conclusions. Against the backdrop of the war in Ukraine, there has been a significant increase in the incidence of chronic viral hepatitis B and C. There continues to be a significant prevalence of viral hepatitis C markers in the Ukrainian population compared to hepatitis B. The increase in the ratio of chronic hepatitis B to acute hepatitis B indicates an improvement in the effectiveness of population testing.
- Open Access
- 29 August 2025
- Published by Poltava State Medical University (PSMU) in The Medical and Ecological Problems
- Vol. 29 (2) , 26-32
MONITORING ANTIMICROBIAL RESISTANCE OF STREPTOCOCCUS PNEUMONIAE
Introduction. Streptococcus pneumoniae remains one of the leading pathogens causing respiratory infections worldwide, particularly in children, the elderly, and patients with chronic comorbidities. It is responsible for community-acquired pneumonia, otitis media, sinusitis, meningitis, and sepsis. The increasing resistance of pneumococcus to antibiotics is a major clinical problem that complicates empirical treatment. The COVID-19 pandemic further aggravated this issue due to widespread and often inappropriate antibiotic use. The aim of this study was to evaluate the role of S. pneumoniae in respiratory infections and analyze the antimicrobial resistance of its isolates in respiratory samples from hospitalized patients during 2018–2024. Methods. A retrospective analysis of respiratory specimens (nasopharyngeal swabs, tonsils, tracheal aspirates, and sputum) was conducted at the Poltava Regional Clinical Infectious Diseases Hospital. The susceptibility of the pneumococcal isolates was determined using the disk diffusion method according to EUCAST. The Antimicrobial Resistance Index (ARI) was calculated based on the frequency of resistant isolates and antibiotic consumption, following the methodology of the Ministry of Health of Ukraine. Results. The proportion of S. pneumoniae increased from 8.2% in 2018 to 10.1% in 2024, with a temporary decline during 2020-2021. Resistance to benzylpenicillin, erythromycin, and levofloxacin peaked in 2021 and subsequently decreased, while vancomycin and linezolid resistance remained low. Antibiotic consumption analysis revealed increased use of fluoroquinolones and carbapenems in 2024. The ARI rose progressively from 0.06 in 2022 to 0.17 in 2024, reflecting the accumulation of resistance. Conclusions. The growing share of S. pneumoniae among respiratory infections and its rising antimicrobial resistance highlight its clinical importance in the post-COVID-19 period. The observed increase in ARI underlines the need for prudent antibiotic use, strengthened resistance monitoring, and adaptation of empirical therapy to local resistance trends.
- 29 August 2025
- Published by Poltava State Medical University (PSMU) in The Medical and Ecological Problems
- Vol. 29 (2) , 26-32
Open AccessMONITORING ANTIMICROBIAL RESISTANCE OF STREPTOCOCCUS PNEUMONIAE
Introduction. Streptococcus pneumoniae remains one of the leading pathogens causing respiratory infections worldwide, particularly in children, the elderly, and patients with chronic comorbidities. It is responsible for community-acquired pneumonia, otitis media, sinusitis, meningitis, and sepsis. The increasing resistance of pneumococcus to antibiotics is a major clinical problem that complicates empirical treatment. The COVID-19 pandemic further aggravated this issue due to widespread and often inappropriate antibiotic use. The aim of this study was to evaluate the role of S. pneumoniae in respiratory infections and analyze the antimicrobial resistance of its isolates in respiratory samples from hospitalized patients during 2018–2024. Methods. A retrospective analysis of respiratory specimens (nasopharyngeal swabs, tonsils, tracheal aspirates, and sputum) was conducted at the Poltava Regional Clinical Infectious Diseases Hospital. The susceptibility of the pneumococcal isolates was determined using the disk diffusion method according to EUCAST. The Antimicrobial Resistance Index (ARI) was calculated based on the frequency of resistant isolates and antibiotic consumption, following the methodology of the Ministry of Health of Ukraine. Results. The proportion of S. pneumoniae increased from 8.2% in 2018 to 10.1% in 2024, with a temporary decline during 2020-2021. Resistance to benzylpenicillin, erythromycin, and levofloxacin peaked in 2021 and subsequently decreased, while vancomycin and linezolid resistance remained low. Antibiotic consumption analysis revealed increased use of fluoroquinolones and carbapenems in 2024. The ARI rose progressively from 0.06 in 2022 to 0.17 in 2024, reflecting the accumulation of resistance. Conclusions. The growing share of S. pneumoniae among respiratory infections and its rising antimicrobial resistance highlight its clinical importance in the post-COVID-19 period. The observed increase in ARI underlines the need for prudent antibiotic use, strengthened resistance monitoring, and adaptation of empirical therapy to local resistance trends.
- Open Access
- 27 February 2025
- Published by Professional Event, LLC
- No. 1,p. 76-82
Study of Public Awareness of Influenza Immunoprophylaxis
Influenza is a serious disease that can provoke exacerbation of chronic diseases and cause life-threatening complications, including pneumonia, bronchitis and, in some cases, inflammation of the brain. The most susceptible to these serious complications are individuals who are in high-risk groups, namely: the elderly persons – over 65 years old, pregnant women, children, and individuals with chronic diseases. The objectives: to analyze the coverage of influenza vaccination of risk groups in Ukraine and the population’s awareness of specific disease prevention. Materials and methods. The study of the population awareness level of specific influenza prevention, and its influence factors was conducted among the population in Shyshatsky united territorial community in the Myrhorod district of the Poltava region by surveying 100 respondents aged 18 to 76 years (average age - 38.40 ± 1.38 years). Among the respondents there were 26 men and 74 women. The survey was conducted in September-October 2023, before the start of the 2023/2024 influenza and acute respiratory viral infection epidemic season, by filling out Google Forms, which were distributed via mobile devices and social networks Facebook and Telegram. The statistical analysis of the data was carried out using mathematical statistics methods – Microsoft Excel spreadsheets and the Statistica 17.0 program (StatSoft Inc., USA). Results. During the epidemic seasons from 2017/2018 to 2022/2023 the level of influenza vaccination coverage was low, about 0.5% of the population of Ukraine in general and 0.9–1.6% of people from medical and epidemic risk groups were vaccinated. The survey results revealed insufficient awareness of the population of the Shyshak territorial community regarding specific influenza prevention. A quarter (22.0%) of respondents had a “negative” attitude towards vaccination, 54.0% of persons had a misconception about its main purpose, only 38.0% of individuals considered it the most effective method of preventing complications, and 32.0% of persons planned to get vaccinated before the epidemic season. Among people over 60 years old, 62.5% had never been vaccinated. At the same time, 25.0% of people considered vaccination the most effective way to prevent the disease. The majority (71.4%) of respondents aged 18–24 years were undecided about their attitude towards influenza vaccination, and only 35.0% of respondents discussed the influenza vaccination with their family doctor. Conclusions. The level of influenza vaccination coverage of the population of Ukraine in general and risk groups in particular during the epidemic seasons from 2017/2018 to 2022/2023 was low. It was established that the population of the Shyshak territorial community is not sufficiently aware of specific influenza prevention issues, which indicates the need to improve the quality of sanitary and educational work and train qualified personnel for this among medical specialists. Providing the vaccine at the state expense would allow 37.0% of respondents to change their decision in favor of vaccination.
- 27 February 2025
- Published by Professional Event, LLC
- No. 1,p. 76-82
Open AccessStudy of Public Awareness of Influenza Immunoprophylaxis
Influenza is a serious disease that can provoke exacerbation of chronic diseases and cause life-threatening complications, including pneumonia, bronchitis and, in some cases, inflammation of the brain. The most susceptible to these serious complications are individuals who are in high-risk groups, namely: the elderly persons – over 65 years old, pregnant women, children, and individuals with chronic diseases. The objectives: to analyze the coverage of influenza vaccination of risk groups in Ukraine and the population’s awareness of specific disease prevention. Materials and methods. The study of the population awareness level of specific influenza prevention, and its influence factors was conducted among the population in Shyshatsky united territorial community in the Myrhorod district of the Poltava region by surveying 100 respondents aged 18 to 76 years (average age - 38.40 ± 1.38 years). Among the respondents there were 26 men and 74 women. The survey was conducted in September-October 2023, before the start of the 2023/2024 influenza and acute respiratory viral infection epidemic season, by filling out Google Forms, which were distributed via mobile devices and social networks Facebook and Telegram. The statistical analysis of the data was carried out using mathematical statistics methods – Microsoft Excel spreadsheets and the Statistica 17.0 program (StatSoft Inc., USA). Results. During the epidemic seasons from 2017/2018 to 2022/2023 the level of influenza vaccination coverage was low, about 0.5% of the population of Ukraine in general and 0.9–1.6% of people from medical and epidemic risk groups were vaccinated. The survey results revealed insufficient awareness of the population of the Shyshak territorial community regarding specific influenza prevention. A quarter (22.0%) of respondents had a “negative” attitude towards vaccination, 54.0% of persons had a misconception about its main purpose, only 38.0% of individuals considered it the most effective method of preventing complications, and 32.0% of persons planned to get vaccinated before the epidemic season. Among people over 60 years old, 62.5% had never been vaccinated. At the same time, 25.0% of people considered vaccination the most effective way to prevent the disease. The majority (71.4%) of respondents aged 18–24 years were undecided about their attitude towards influenza vaccination, and only 35.0% of respondents discussed the influenza vaccination with their family doctor. Conclusions. The level of influenza vaccination coverage of the population of Ukraine in general and risk groups in particular during the epidemic seasons from 2017/2018 to 2022/2023 was low. It was established that the population of the Shyshak territorial community is not sufficiently aware of specific influenza prevention issues, which indicates the need to improve the quality of sanitary and educational work and train qualified personnel for this among medical specialists. Providing the vaccine at the state expense would allow 37.0% of respondents to change their decision in favor of vaccination.
- Open Access
- 5 October 2020
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 25 (3) , 204-210
West Nile Fever in the central part of Ukraine
West Nile Fever in the central part of Ukraine
- 5 October 2020
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 25 (3) , 204-210
Open AccessWest Nile Fever in the central part of Ukraine
West Nile Fever in the central part of Ukraine
- 1 April 2018
- Vol. 71, 242-245
Opisthorchiasis and viral hepatitis b: clinical cases.
Introduction: Among the cases of biohelminthosis, which are registered in Ukraine, opisthorchiasis is the most common and constitutes the second largest centre in Europe. Due to the growth of migration processes and global tourism, opisthorchiasis is becoming increasingly relevant for the countries of the European Union and the United States. Under modern conditions, the clinical course of many infectious and parasitic diseases has changed. The aim: The present paper discusses and analyzes the cases of opisthorchiasis and hepatitis B virus which are challenging in terms of diagnostics and choice of treatment tactics. Conclusion: The course of acute infections, the formation of results and the effectiveness of treatment are influenced by a number of factors, among which mixed infections are of particular interest.
- 1 April 2018
- Vol. 71, 242-245
Opisthorchiasis and viral hepatitis b: clinical cases.
Introduction: Among the cases of biohelminthosis, which are registered in Ukraine, opisthorchiasis is the most common and constitutes the second largest centre in Europe. Due to the growth of migration processes and global tourism, opisthorchiasis is becoming increasingly relevant for the countries of the European Union and the United States. Under modern conditions, the clinical course of many infectious and parasitic diseases has changed. The aim: The present paper discusses and analyzes the cases of opisthorchiasis and hepatitis B virus which are challenging in terms of diagnostics and choice of treatment tactics. Conclusion: The course of acute infections, the formation of results and the effectiveness of treatment are influenced by a number of factors, among which mixed infections are of particular interest.
- 1 January 2017
- Published by Scientific Society Anatomists, Histologists, and Embryologists, Ukraine in World of Medicine and Biology
- Vol. 13 (62) , 209-212
DISTANCE LEARNING AS AN INNOVATIVE FORM OF POSTGRADUATE STUDIES IN HIGHER MEDICAL EDUCATION
The article presents the experience of implementing distance technologies in postgraduate education of doctors at the Department of Infectious Disease
- 1 January 2017
- Published by Scientific Society Anatomists, Histologists, and Embryologists, Ukraine in World of Medicine and Biology
- Vol. 13 (62) , 209-212
DISTANCE LEARNING AS AN INNOVATIVE FORM OF POSTGRADUATE STUDIES IN HIGHER MEDICAL EDUCATION
The article presents the experience of implementing distance technologies in postgraduate education of doctors at the Department of Infectious Disease